Table 1:
Table 1:
Parameters used for different fat-suppression sequences on a 3T scannera
| Axial STIR | Axial T2WI | Axial Gad-T1WI | Axial Gad-T1WI | |
|---|---|---|---|---|
| TSE | mDixon TSE | SPIR TSE | mDixon TSE | |
| Coil | 16 Channel | 16 Channel | 16 Channel | 16 Channel |
| SENSE NV | SENSE NV | SENSE NV | SENSE NV | |
| TR/TE | 3000/15 ms | 3000/80 ms | 600/9.2 ms | 500/10 ms |
| Section thickness/intersection gap | 3/1 mm | 3/1 mm | 3/1 mm | 3/1 mm |
| No. of axial images | 40 | 40 | 40 | 40 |
| FS technique | Inversion recovery (TI = 200 ms) | mDixon | SPIR | mDixon |
| Acquisition matrix | 200 × 141 | 232 × 232 | 288 × 196 | 204 × 199 |
| NEX | 2 | 1 | 1 | 1 |
| Acquisition time | 4 min, 56 sec | 2 min, 2 sec | 3 min, 2 sec | 2 min, 8 sec |
| Parallel imaging | Yes | Yes | Yes | Yes |
| Gadolinium contrast | N/A | N/A | 0.1 mmol/kg gadodiamide (Gd-DTPA) (ProHance) | 0.1 mmol/kg gadodiamide (Gd-DTPA) (ProHance) |
Note:—SENSE indicates sensitivity encoding; N/A, not applicable; NV, NeuroVascular.
↵a Achieva; Philips Healthcare.
Related Articles
Cited By...
- Development and implementation of optimized endogenous contrast sequences for delineation in adaptive radiotherapy on a 1.5T MR-Linear-accelerator (MR-Linac): A prospective R-IDEAL Stage 0-2a quantitative/qualitative evaluation of in vivo site-specific quality-assurance using a 3D T2 fat-suppressed platform for head and neck cancer
- 4D-Dynamic Contrast-Enhanced MRI for Preoperative Localization in Patients with Primary Hyperparathyroidism